First Time Loading...

Findex Inc
TSE:3649

Watchlist Manager
Findex Inc Logo
Findex Inc
TSE:3649
Watchlist
Price: 1 018 JPY 0.49% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one Findex Inc stock under the Base Case scenario is 755.29 JPY. Compared to the current market price of 1 018 JPY, Findex Inc is Overvalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
755.29 JPY
Overvaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5
P/S
P/S
Price to Sales
5
vs History
52
vs Industry
27
Median 3Y
3.9
Median 5Y
5.1
Industry
2.4
Forward
4.6
More Details
24.7
P/E
P/E
Price to Earnings
24.7
vs History
77
vs Industry
23
Median 3Y
27.3
Median 5Y
31.1
Industry
23.2
Forward
23.5
More Details
31
P/OCF
P/OCF
Price to OCF
31
vs History
44
vs Industry
12
Median 3Y
31.6
Median 5Y
30.2
Industry
15.5
More Details
46.6
P/FCFE
P/FCFE
Price to FCFE
46.6
vs History
46
vs Industry
13
Median 3Y
47.8
Median 5Y
45.4
Industry
23.5
More Details
5.4
P/B
P/B
Price to Book Value
5.4
vs History
63
vs Industry
15
Median 3Y
5
Median 5Y
7.2
Industry
2.2
More Details
4.5
EV/S
EV/S
Enterprise Value to Sales
4.5
vs History
53
vs Industry
27
Median 3Y
3.4
Median 5Y
4.7
Industry
2.5
Forward
4.1
More Details
7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7
vs History
60
vs Industry
33
Median 3Y
6.1
Median 5Y
8.1
Industry
5.2
More Details
13.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.3
vs History
57
vs Industry
26
Median 3Y
13.1
Median 5Y
14.5
Industry
12.5
Forward
12.1
More Details
15.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.6
vs History
73
vs Industry
29
Median 3Y
16.3
Median 5Y
18.6
Industry
17.2
More Details
27.8
EV/OCF
EV/OCF
Enterprise Value to OCF
27.8
vs History
44
vs Industry
15
Median 3Y
28.2
Median 5Y
26.8
Industry
15.1
More Details
41.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
41.8
vs History
53
vs Industry
13
Median 3Y
48.1
Median 5Y
42.8
Industry
19.7
More Details
7.3
EV/IC
EV/IC
Enterprise Value to IC
7.3
vs History
74
vs Industry
12
Median 3Y
7.6
Median 5Y
9.3
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Findex Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Findex Inc
TSE:3649
26.1B JPY 5 24.7 13.3 15.6
US
Veeva Systems Inc
NYSE:VEEV
32.5B USD 13.7 61.8 61.5 66.2
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.7B AUD 80.1 168 115.5 115.5
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.9 -351 -182.6 -169.7
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.7 32.9 21.9 23.3
SE
Sectra AB
STO:SECT B
42B SEK 25.6 98.9 -65.5 -65.5
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.9 25.8 274.3
US
Certara Inc
NASDAQ:CERT
2.8B USD 7.9 -50.9 45.6 457
P/E Multiple
Earnings Growth
JP
Findex Inc
TSE:3649
Average P/E: 65.4
24.7
N/A
US
Veeva Systems Inc
NYSE:VEEV
61.8
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
168
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -351 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
32.9
79%
SE
Sectra AB
STO:SECT B
98.9
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -21.9 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.9 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
Findex Inc
TSE:3649
Average EV/EBITDA: 36.9
13.3
N/A
US
Veeva Systems Inc
NYSE:VEEV
61.5
221%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
115.5
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -182.6 N/A
JP
M3 Inc
TSE:2413
12.5
24%
US
Doximity Inc
NYSE:DOCS
21.9
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.5 N/A
US
Evolent Health Inc
NYSE:EVH
25.8
194%
US
Certara Inc
NASDAQ:CERT
45.6
143%
EV/EBIT Multiple
EBIT Growth
JP
Findex Inc
TSE:3649
Average EV/EBIT: 124
15.6
N/A
US
Veeva Systems Inc
NYSE:VEEV
66.2
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
115.5
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -169.7 N/A
JP
M3 Inc
TSE:2413
14.1
N/A
US
Doximity Inc
NYSE:DOCS
23.3
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.5 N/A
US
Evolent Health Inc
NYSE:EVH
274.3
2 086%
US
Certara Inc
NASDAQ:CERT
457
2 181%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.